WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday. Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can target the protein have [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows | 5 | 7 | 14-07-2026 |
| 2 | An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows | 0 | 6.02 | 14-07-2026 |
| 3 | New experimental Alzheimer’s drug shows potential after study shows slower cognitive decline | 2 | 6 | 14-07-2026 |
| 4 | Scientists May Have Found What Really Triggers Alzheimer’s Disease | 2 | 7 | 19-06-2026 |
| 5 | В Британии представили результаты генной терапии от болезни Альцгеймера | 5 | 7 | 16-07-2026 |
| 6 | Найден способ отсрочить развитие болезни Альцгеймера на три года | 7 | 8 | 16-07-2026 |
| 7 | Resetting the body’s rhythm could protect the brain from Alzheimer’s | 5 | 7 | 01-11-2025 |
| 8 | Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease | 0 | 7 | 15-07-2026 |
| 9 | Препарат восстановил повреждения ДНК при болезни Альцгеймера | 6 | 8 | 09-07-2026 |
| 10 | Science & Medicine: Pursuing precision medicine for Alzheimer's disease | 0 | 7.06 | 12-07-2026 |